OCULAR THERAPEUTIX INC (OCUL) Institutional Ownership Changes & 13F Activity
OCULAR THERAPEUTIX INC (OCUL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Deep Track Capital, Lp, Avoro Capital Advisors Llc, Venrock Adviser, Llc, Price T Rowe Associates Inc, and Logos Global Management Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Versant Capital Management, Inc | Buy | +76 | +21.2% | 435 | $3.34K | Q3 2026 | Oct 02, 2026 |
| State Street Corp | Sell | -5,233,282 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 22, 2026 |
| Knoll Capital Management, Llc | Sell | -1,150,400 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 10, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -229,256 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Sell | -127 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 04, 2026 |
| Second Line Capital, Llc | Sell | -638,640 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 02, 2026 |
| Citadel Advisors Llc | Sell | -310,484 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 02, 2026 |
| Allianz Asset Management Gmbh | Sell | -15,200 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Sell | -49,629 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -207,784 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 24, 2026 |
| Assenagon Asset Management S.A. | Sell | -45,600 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 21, 2026 |
| Mercer Global Advisors Inc | Sell | -36,859 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 19, 2026 |
| Ratan Capital Management Lp | Sell | -70,792 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 18, 2026 |
| Deep Track Capital, Lp | Sell | -19,686,282 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Avoro Capital Advisors Llc | Sell | -12,540,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Venrock Adviser, Llc | Sell | -10,346,926 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -7,623,533 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Sell | -5,300,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -3,292,193 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -2,270,707 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Octagon Capital Advisors Lp | Sell | -2,075,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -1,761,754 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Sell | -1,667,609 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Tcg Crossover Management, Llc | Sell | -1,647,752 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Sell | -1,550,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -1,533,438 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Defilade Capital Management, L.P. | Sell | -1,490,286 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -1,415,913 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Invesco Ltd. | Sell | -1,344,391 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Boxer Capital Management, Llc | Sell | -1,300,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
Frequently asked questions about OCUL activity
Which institutional owners are buying OCUL?
Institutional owners buying OCUL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OCUL activity?
"Buy" means an investor increased their reported position in OCUL compared to the prior reporting period. This reflects growing exposure to OCULAR THERAPEUTIX INC (OCUL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OCUL increasing?
Institutional interest in OCUL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related OCUL Institutional Insights
- OCUL Overview
- OCUL 13F Institutional Holders
- OCUL Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- OCUL Insider Trading & SEC Form 4 Activity
- OCUL Articles
- Top Institutional Investor Stock Rankings